- Home
- PRTH vs XNCR Comparison
PRTH vs XNCR Comparison
Compare PRTH & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTH
- XNCR
- Stock Information
- Founded
- PRTH 2005
- XNCR 1997
- Country
- PRTH United States
- XNCR United States
- Employees
- PRTH N/A
- XNCR N/A
- Industry
- PRTH EDP Services
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- PRTH Technology
- XNCR Health Care
- Exchange
- PRTH Nasdaq
- XNCR Nasdaq
- Market Cap
- PRTH 550.3M
- XNCR 547.8M
- IPO Year
- PRTH N/A
- XNCR 2013
- Fundamental
- Price
- PRTH $8.43
- XNCR $8.41
- Analyst Decision
- PRTH Strong Buy
- XNCR Buy
- Analyst Count
- PRTH 4
- XNCR 9
- Target Price
- PRTH $12.25
- XNCR $25.00
- AVG Volume (30 Days)
- PRTH 560.6K
- XNCR 718.6K
- Earning Date
- PRTH 08-07-2025
- XNCR 08-06-2025
- Dividend Yield
- PRTH N/A
- XNCR N/A
- EPS Growth
- PRTH N/A
- XNCR N/A
- EPS
- PRTH 0.26
- XNCR N/A
- Revenue
- PRTH $918,558,000.00
- XNCR $146,929,000.00
- Revenue This Year
- PRTH $12.76
- XNCR N/A
- Revenue Next Year
- PRTH $10.49
- XNCR $28.84
- P/E Ratio
- PRTH $31.83
- XNCR N/A
- Revenue Growth
- PRTH 12.86
- XNCR N/A
- 52 Week Low
- PRTH $4.89
- XNCR $6.92
- 52 Week High
- PRTH $12.47
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- PRTH 63.65
- XNCR 55.89
- Support Level
- PRTH $7.64
- XNCR $7.13
- Resistance Level
- PRTH $8.17
- XNCR $7.99
- Average True Range (ATR)
- PRTH 0.47
- XNCR 0.53
- MACD
- PRTH 0.13
- XNCR 0.06
- Stochastic Oscillator
- PRTH 91.33
- XNCR 94.90
About PRTH Priority Technology Holdings Inc.
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.